Transaction #17778 · Form 4 · 0001104659-25-119985
Astrana Health, Inc. · Exercise / conversion · Common Stock
Astrana Health, Inc. · Transacted December 8, 2025 · Filed December 10, 2025
What does this filing report?
An SEC Form 4 filing for Astrana Health, Inc. records an exercise / conversion involving Common Stock on December 8, 2025. The reported quantity was 29,502. The filing date is December 10, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Astrana Health, Inc.
- Company CIK
- 0001083446
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 29,502
- Reported price
- 17.78
- Reference value
- 524,545.56
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 459,122
- Ownership description
- Not reported
- SEC acceptance time
- Dec 10, 2025, 4:15 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Lam Thomas S. ↗
Director
CIK 0001664499
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- These securities are beneficially owned by Allied Physicians of California, a Professional Medical Corporation, of which the Reporting Person is the Chief Executive Officer and Chief Financial Officer and a director and stockholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F2
- These stock options were fully vested and exercisable.
- F3
- Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 77,500 shares, which will vest in three equal annual installments beginning on March 5, 2026; and (ii) 26,667 shares, which will vest upon achievement of certain pre-established performance goals.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.